Back to 
Mubadala Investment Co PJSC
Mubadala Investment Co PJSC
HALO
2 quarters
Position history for Mubadala Investment Co PJSC's holdings in Halozyme Therapeutics, Inc.
No. Mubadala Investment Co PJSC exited its HALO (Halozyme Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 35,815 shares worth $2.4M. Mubadala Investment Co PJSC first reported HALO in Q4 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$2.4M
Total Shares Change
-35,815
Quarter-by-Quarter History
Other major holders of HALO: BlackRock, Inc., BlackRock Finance, Inc.